
Eupraxia Pharmaceuticals Virtual Event: Catalyst Preview – An Overview of the Upcoming Interim Data for EP-104GI for Eosinophilic Esophagitis (EoE)
| DATE: | November 13, 2026 |
|---|---|
| TIME: | 8:30 AM EST |
| LOCATION: | Virtual |
About The Event
Join Eupraxia Pharmaceuticals for a virtual webcast with company management to discuss an important upcoming catalyst.
In December, interim data from the placebo-controlled portion of the RESOLVE trial will be released. During the webinar, management will review clinical data from EP-104GI in EoE from Part 1 of the trial and provide details of what to expect in the interim data for Part 2.